All In Biotech

Drug Trial Radar · NCT00912301

Cheno Effect on Transit in Health and IBS-C

Effect of Chenodeoxycholic Acid on Gastrointestinal Transit and Colonic Functions in Health and Constipation-predominant Irritable Bowel Syndrome (IBS-C)

Last checked: Nov 19, 2026Latest source record: Jul 2, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

36

Actual

Start

Apr 2009

Primary completion

Nov 2009

Study completion Dec 2009

Sponsor

Lead sponsor
Mayo ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Center for Research Resources (NCRR)
First posted
Jun 3, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study hypothesis is that the naturally occurring bile acid, chenodeoxycholic acid, induces acceleration of colonic transit in health and in patients with constipation-predominant Irritable Bowel Syndrome (IBS-C).

Conditions

  • Constipation-predominant Irritable Bowel Syndrome

Interventions

  • Sodium chenodeoxycholate (NaCDC)Drug

    500 or 1000 milligrams NaCDC per day each for a period of 4 days

  • PlaceboOther

    Placebo capsules with identical appearance to the study drug were prepared by the Mayo Clinic research pharmacy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Colonic Geometric Center at 24 Hours (GC24)Time frame: after 4 days of treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Rochester, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.